WASHINGTON, November 23, 2015: Morgan Lewis is serving as lead U.S. antitrust counsel to Pfizer in its combination with Allergan announced earlier today, which will establish a new global biopharmaceutical leader.
The Morgan Lewis team is led by partners Scott Stempel and Harry Robins. Support is provided by partner Clay Everett and associates David Brenneman, Martin d’Halluin, Katie Glynn, and Maria Luisa Di Lauro.
When completed, the transaction will be the largest pharmaceutical industry M&A transaction in history and among the largest M&A transactions of any type. Including this deal, the Morgan Lewis antitrust team has worked on three of the seven largest pharmaceutical transactions ever.
The transaction is expected to close in the second half of 2016. A press release issued by Pfizer can be read here.